Table 3.
ADMET profiling of the best-selected phytochemicals.
| Category | Property | Myricetin | Malvidin | Rhamnetin | Quercetin | Isorhamnetin | Okanin | Callistephin |
|---|---|---|---|---|---|---|---|---|
| Absorption | Caco-2 > −5.15 | −5.653 | −5.159 | −5.109 | −5.204 | −5.056 | −5.375 | −6.196 |
| Pgp-Substrate | −−− | ++ | −−− | −−− | −−− | −−− | + | |
| Pgp-Inhibitor | −−− | −−− | −−− | −−− | −−− | −−− | −−− | |
| HIA | −−− | −−− | −−− | −−− | −−− | −−− | ++ | |
| Distribution | BBB | −−− | −−− | −−− | −−− | −−− | −−− | −− |
| PPB | 92.77% | 93.13% | 96.30% | 95.45% | 96.24% | 99.08% | 89.62% | |
| Metabolism | CYP1A2-Inhibitor | ++ | ++ | +++ | +++ | +++ | + | −−− |
| CYP1A2 substrate | −− | ++ | + | −− | ++ | −−− | −−− | |
| CYP2C19 inhibitor | −−− | −−− | −−− | −−− | −− | −−− | −−− | |
| CYP2C19 substrate | −−− | −−− | −−− | −−− | −−− | −−− | −−− | |
| CYP2C9 inhibitor | + | −−− | + | + | + | + | −−− | |
| CYP2C9 substrate | − | ++ | ++ | + | ++ | − | − | |
| CYP2D6 inhibitor | −−− | −−− | − | − | + | −−− | −−− | |
| CYP2D6 substrate | −− | + | − | −− | − | −− | −− | |
| CYP3A4 inhibitor | −− | −− | −− | − | + | −− | −−− | |
| CYP3A4 substrate | −−− | −− | −−− | −− | −−− | −− | −−− | |
| Excretion | Clearance | 7.716 | 11.093 | 8.284 | 6.991 | 16.361 | 7.971 | |
| Toxicity | AMES | − | −− | + | + | + | ++ | ++ |
| hERG | −− | −− | −−− | −−− | −−− | −−− | −−− | |
| FDAMDD | + | +++ | − | −−− | −−− | − | −−− | |
| H-HT | −−− | −−− | −−− | −−− | −−− | −− | −− | |
| Category | Property | Kaempferol | Gallic Acid | Rosavin | Esculin | Robinetin | Tricin | |
| Absorption | Caco-2 > −5.15 | −4.974 | −5.728 | −5.406 | −5.950 | −5.325 | −4.970 | |
| Pgp-Substrate | −−− | −−− | − | − | −−− | +++ | ||
| Pgp-Inhibitor | −−− | −−− | −−− | −−− | −−− | −−− | ||
| HIA | −−− | −−− | +++ | ++ | −−− | −− | ||
| Distribution | BBB | −−− | −−− | − | ++ | −−− | −−− | |
| PPB | 97.86% | 53.49% | 43.91% | 56.10% | 94.64% | 91.48% | ||
| Metabolism | CYP1A2-Inhibitor | +++ | −−− | −−− | −−− | ++ | +++ | |
| CYP1A2 substrate | −− | −−− | −−− | −−− | −− | +++ | ||
| CYP2C19 inhibitor | −− | −−− | −−− | −−− | −−− | −− | ||
| CYP2C19 substrate | −−− | −−− | −−− | −−− | −−− | −−− | ||
| CYP2C9 inhibitor | + | −− | −−− | −−− | + | + | ||
| CYP2C9 substrate | ++ | −−− | −− | − | − | ++ | ||
| CYP2D6 inhibitor | ++ | −−− | −−− | −−− | −− | + | ||
| CYP2D6 substrate | −− | −− | −− | −− | −− | ++ | ||
| CYP3A4 inhibitor | + | −−− | −−− | −−− | − | + | ||
| CYP3A4 substrate | −−− | −−− | −−− | −−− | −−− | −− | ||
| Excretion | Clearance | 6.868 | 10.108 | 1.218 | 4.015 | 7.773 | 6.626 | |
| Toxicity | AMES | + | −−− | −− | −− | + | − | |
| hERG | −−− | −−− | −−− | −−− | −−− | −− | ||
| FDAMDD | −− | −−− | −−− | −−− | − | ++ | ||
| H-HT | −−− | −− | −− | −− | −− | −−− | ||
Pgp: P-glycoprotein; HIA: Human Intestinal Absorption; BBB: Blood–Brain Barrier; PPB: Plasma protein binding. The values are represented with different symbols for prediction probability: 0–0.1 (−−−), 0.1–0.3 (−−), 0.3–0.5 (−), 0.5–0.7 (+), 0.7–0.9 (++), and 0.9–1.0 (+++). The sign ‘+++’ or ‘++’ represents the like hood of toxic or defective, while ‘−−−’ or ‘−’ represents nontoxic or appropriate. Tip: For the classification endpoints, the prediction probability values are transformed into six symbols: 0–0.1 (−−−), 0.1–0.3 (−−), 0.3–0.5 (−), 0.5–0.7 (+), 0.7–0.9 (++), and 0.9–1.0 (+++).